LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer

您当前的位置：

首页 >

文章列表页 >

LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer

更新时间：2022-06-24

- LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer
- Genes & Diseases Vol. 9, Issue 4, (2022)
- 作者机构：
  
  1. Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University,Shanghai,PR China,200127
  2. Department of General Surgery, Beijing Friendship Hospital, Capital Medical University,Beijing,PR China,100050
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2021.10.001
  CLC：
- Published：2022，
  
  Published Online：1 July 2022，
扫描看全文
Yaqian Xu, Chenwei Yuan, Jing Peng, et al. LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer. [J]. Genes & Diseases 9(4).(2022)
DOI：

Yaqian Xu, Chenwei Yuan, Jing Peng, et al. LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer. [J]. Genes & Diseases 9(4).(2022) DOI： 10.1016/j.gendis.2021.10.001.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰